The Troponin T Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative, membrane based immunoassay for the detection of cTnT in whole blood, serum or plasma. The membrane is pre-coated with Strepavidin-IgG on the test line region of the test and cTnT-biotin on the sample pad. During testing, the whole blood, serum or plasma specimen reacts with the cTnT-biotin on the sample pad frist, then migrates and react with the particle coated with anti-cTnT antibodies. The mixture migrates upward on the membrane chromatographically by capillary action to react with capture reagent on the membrane and generate a colored line. The presence of this colored line in the test line region indicates a positive result, while its absence indicates a negative result. To serve as a procedural control, a colored line will always appear in the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.

Sensitivity and Specificity

The Troponin T Rapid Test Device (Whole Blood/Serum/Plasma) has been evaluated with a leading commercial cTnT EIA test using clinical specimens. The results show that the sensitivity of the Troponin T Rapid Test Device (Whole Blood/Serum/Plasma) is 98.3% and the specificity is 98.4% relative to the leading EIA test.

Troponin T Rapid Test Device vs. EIA